New evidence highlights how timing and physiology-based biomarkers can outperform single measurements in critical care and oncology-adjacent decision-making. In a multicenter ICU study of nearly 6,000 gastrointestinal bleeding patients, hourly blood urea nitrogen trajectories during the first 24 hours predicted mortality more strongly than admission single values. Separately, a Finnish cohort study found that while Parkinson’s patients have roughly doubled hip fracture risk, osteoporosis drug use rates after fractures were not consistently higher than in matched controls—only about one in five patients in either group received bone-protecting therapy after a hip fracture, pointing to a fall-prevention and care-gap problem. Together, the studies reinforce a clinical reality for biotech and health systems: risk modeling needs dynamic measurements and follow-through on preventive interventions, not just baseline lab values. From a translational standpoint, these findings can feed into algorithm development and endpoints selection for trials targeting acute-risk stratification and post-event preventive care.